Meric Mericliler, MD
Hematology & Oncology · Washington, DCNPI 1659866093
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $531 of the $634 with a category attached, or 83.7%. 12 manufacturers reported payments, led by Sobi, Inc at 25.2% of the total. That places this record below the midpoint for hematology & oncology clinicians in DC, where the typical reported total is $4,025.
Across 16 payments — averaging $39.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sobi, Inc$160
- Sanofi$150
- Seagen Inc.$83
- Johnson & Johnson$41
- Daiichi Sankyo Inc.$38
- Merck$32
- plus $131 from 6 others
What the payments were for
- Food & beverage$53184%
- Education$10316%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sobi, Inc | 2 | $160 |
| Sanofi | 2 | $150 |
| Seagen Inc. | 1 | $83 |
| Johnson & Johnson | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Merck | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Beone Medicines USA, Inc. | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Gamifant$125
How this compares
$634 in reported general payments places this provider in the 30th percentile of 69 hematology & oncology providers in District of Columbia.
See all hematology & oncology providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Washington
- Imadeddine TabbaraWashington$1.2M
- John MarshallWashington$525K
- Catherine BroomeWashington$504K
- Craig KesslerWashington$449K
- Benjamin WeinbergWashington$326K
- Claudine IsaacsWashington$241K
- Chul KimWashington$173K
- Christopher GallagherWashington$109K
- Neil ShahWashington$76K
- Vered StearnsWashington$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.